Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BitMEX Study Reveals Superior Performance of Perpetual Swap Listings, with an Average Price Gain of 62.55%, Outperforming Competitors
-
ASUS Unveils Signature Edition Zenbook Series at “Design You Can Feel” Exhibition
-
ASUS “Design You Can Feel” Exhibition Opens at Milan Design Week 2025
-
Qualifacts to Host Executive Webinar on Building Financial Resilience in Behavioral Health Amidst Funding Volatility
-
ImmuCell Hires Chief Financial Officer
-
Disguise and BBC Studios Extend Partnership for Bluey Costume Line Across North America
-
Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology
-
Veritext Legal Solutions Pioneers Sustainability in the Legal Services Industry
-
ProSearch Continues Expansion of Legal Industry Support with New Event Investments and Expert Speakers
-
Check Point Recognized for #1 AI-Powered Cyber Security Platform by Miercom
-
Rob McCain Appointed as Senior Vice President, Market President of Charlotte Metropolitan Area
-
Carronade Capital Files Preliminary Proxy Statement for Cannae Holdings 2025 Annual Meeting
-
Your Number, Your Identity: How New York Mobile Is Turning Personalized Phone Numbers Into the New Digital Status Symbol
-
Axalta Takes Home Two Prestigious Edison Awards™
-
Rail Vision Announces Participation in the LD Micro Invitational XV
-
LPL Financial Announces Strategic Relationship with First Horizon Bank
-
Surplus Solutions, an NMS Capital Portfolio Company, Expands Capabilities in Refurbished Laboratory Equipment and Technical Services; Announces Partnership with Certified Genetool
-
Zero Hash Further Enhances its Leading Position as the Crypto-as-a-service provider for Brokerage Firms
-
Kepler Announces On-Orbit Compute Capacity on Optical Data Relay Network
-
BOXX Showcases AMD Threadripper-Based Workstation at 2025 NAB Show
-
Nelipak® Healthcare Packaging Expands Commitment to Serve Customers in Asia-Pacific Region with its Sterile Barrier Medical Packaging Products
-
California Resources Corporation Schedules First Quarter 2025 Earnings Conference Call
-
Dr. Chris Meek Announces the Release of Second Book: “Everyday Triumph”
-
NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th
-
Varonis Appoints New Country Manager in Japan
-
RESOLUTIONS OF MARTELA CORPORATION ANNUAL GENERAL MEETING
-
Sharecare Names Industry Veteran Elizabeth Delahoussaye as Chief Privacy Officer of Health Data Solutions
-
Getty Images Named as Exclusive Worldwide Photographic Licensing Partner of WWE®
-
Lánasjóður sveitarfélaga - Útboð LSS 39 0303 og LSS151155
-
Global Survey: Educators Anticipate Little Impact from Artificial Intelligence on Students’ Biggest Challenges
-
Dmitri Alperovitch Headlines SANS Security West 2025 with Explosive Keynote on Cyber War's Future
-
OBLUE Welcomes Two World-Class Experts to Its Brand Witness Board
-
Form 8.3 - [Insert name of offeree or offeror]
-
Notice of Annual General Meeting in Karolinska Development AB (publ)
-
GlucoTonic Reviews (EXPOSED): Is This Natural Formula a Real Diabetes Breakthrough or Just Clever Hype?
-
Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies
-
Better Choice Company Issues Stock Dividend of 0.35 per Share for Each Share Held for Stockholders of Record as of April 17, 2025
-
Senti Bio Joins Webull Corporate Connect Service Platform
-
Form 8.3 - Warehouse REIT Plc
-
ProvaDent Reviews (EXPOSED): Dentist Reveals If This Probiotic Tooth Saver Is Too Good to Be True
-
Form 8.3 - Renewi Plc
-
-
Invesco Ltd: Form 8.3 -QUALCOMM Inc; Public dealing disclosure
-
Form 8.3 - Primary Health Properties Plc
-
Form 8.3 - NIOX Group Plc
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
Resolutions of Baltic Horizon Fund repeat general meeting
-
Noom appoints Dr. Jeffrey Egler as Chief Medical Officer to Lead Innovation in Healthy Aging and Longevity
-
Form 8.3 - LondonMetric Property Plc
-
Form 8.3 - Life Science REIT Plc
